Literature DB >> 32242202

Editorial: COVID-19 and Older Adults.

J E Morley1, B Vellas.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32242202      PMCID: PMC7113379          DOI: 10.1007/s12603-020-1349-9

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


× No keyword cloud information.
“There is a significant probability of a large scale and lethal modern day pandemic occurring in our lifetimes.” ~Bill Gates Since the great plague and cholera epidemics that occurred before the twentieth century, there have been a number of other pandemics starting with the Spanish Flu in 1918. In December, 2019, a new coronavirus, now recognized as COVID-19, began to cause respiratory illness in Wuhan, China. The epidemic began in a fish market and is most similar to snake, pangolin, horseshoe crab, and bat corona viruses. In humans it is spread by respiratory droplets. It can remain alive on plastic surfaces for over 72 hours. It is spread by respiratory droplets. At the Shattuck lecture in Boston in 2018. Bill Gates called for a “clear road map for a comprehensive pandemic preparedness and response system (1).”Since the great plague and cholera epidemics that occurred before the twentieth century, there have been a number of other pandemics starting with the Spanish Flu in 1918. In December, 2019, a new coronavirus, now recognized as COVID-19, began to cause respiratory illness in Wuhan, China. The epidemic began in a fish market and is most similar to snake, pangolin, horseshoe crab, and bat corona viruses. In humans it is spread by respiratory droplets. It can remain alive on plastic surfaces for over 72 hours. It is spread by respiratory droplets. At the Shattuck lecture in Boston in 2018. Bill Gates called for a “clear road map for a comprehensive pandemic preparedness and response system (1).” COVID-19 presents with nasal secretions, cough, dyspnea, fever, myalgia and occasionally diarrhea. Around 15% may go on to develop acute respiratory distress syndrome for 5 days, but may last up to 14 days. Viral shedding may last up to 37 days. Over 95% of hospitalized patients have abnormal chest computed tomography (2). On CT, ground glass opacities with a reticular pattern, a subplural line, fibrotic streaks and an air bronchogram were the most common signs (3). These findings allowed COVID-19 pneumonia to be separated from classical viral pneumonia. From the laboratory point of view lymphocytopenia, elevated C-reactive protein, elevated interleukin-6, elevated lactic dehydrogenase, hypoalbuminemia, a decreased CD8 count increased ferritin and decreased procalcitonin (4). In addition, very high angiotensin II levels were present. Highly elevated d-dimer levels are associated with mortality for people on ventilators. Besides acute respiratory distress syndrome severely ill patients develop myocardial damage and this is associated with increased mortality. Kidney and liver disease also occur. COVID-19 enters the central nervous system and increases inflammatory cytokines which can be expected to lead to delirium. Older people also have an increase in delirium and do not always have an increase in fever. The prevalence of COVID-19 in the community is uncertain as it appears a number of persons may not show symptoms. It would appear that the mortality may be as low as 0.6% (5). It is clear that older persons are at a much higher risk of mortality (about 15%) than younger persons (5). Persons with comorbidity are at an increased risk. It is suggested that the FRAIL screen is used to detect persons at increased risk (6, 7, 8). Persons with hypertension and diabetes mellitus are at increased risk possibly due to alterations in the angiotensin converting enzyme 2 (ACE 2) receptor produced by ACE 1 inhibitors. Primary prevention especially for older persons with comorbidity is social distancing and where possible social isolation. For older persons the problem with social isolation is loneliness (9). Loneliness leads to depression, cognitive dysfunction, disability, cardiovascular disease and increased mortality. Obviously, prevention also requires regular hand washing and cleaning of surfaces. Wearing a mask does not provide protection for the individual. Finally, the first vaccine has just started testing. If it or other vaccines under development mount an adequate antibody response there will be a need to try to rapidly bring it to the general public. It is important to recognize that some persons, like “Typhoid Mary” who spread typhoid fever in the 1910s, may be asymptomatic. Thus, distance must be kept from everybody. At present, while there are no established drugs to treat COVID-19, some are showing promise. Chloroquine phosphate, an anti-malarial, has been shown to be useful in treating COVID-19 pneumonia (10). Remdesivir, an antiviral drug developed to treat Ebola, has been suggested to have positive effects in COVID-19 infected patients with severe respiratory disease (11). These patients developed gastrointestinal symptoms and elevated liver function tests. Some patients with severe COVID-19 disease develop cytokine storm and this may be prevented with toclizumab. Passive infusion of polyclonal plasma antibodies from persons who have had COVID-19 infection has been suggested and monoclonal antibodies to COVID-19 are under development (12). Finally, COVID-19 binds to the soluble portion of the ACE-2 receptor and this seems essential for the virus to enter cells. The possibility of a monoclonal antibody to the soluble portion of the ACE-2 receptor is under consideration. It is uncertain whether stopping the use of ACE 1 inhibitors which increase ACE-2 receptors should be undertaken. However, this may explain the increased virulence of COVID-19 in persons with hypertension and diabetes mellitus. COVID-19 infected patients may do worse if taking ibuprofen, so it is recommended that patients take acetaminophen or paracetamol for fever and pain. In conclusion, COVID-19 represents a major threat to older adults. This is particularly true in older persons with frailty and co-morbidity. Other factors that appear to play a role in the increased severity in older persons are the decline in immune function and alterations in the ACE 2 receptor. There is need for rapid development of a COVID-19 vaccine and its deployment among the population. In the meantime, social distancing, careful hand washing and using antiseptic wipes to clean surfaces and door handles before touching them represent the appropriate preventive measures. During the pandemic it is especially important to isolate older persons in nursing homes and to provide support when nursing home staff need to be quarantined. With good population health approaches, it is expected that the COVID-19 pandemic will be controlled in a relatively short time period.
  11 in total

1.  Utility of the FRAIL Questionnaire in Detecting Heart Failure with Preserved Ejection Fraction.

Authors:  J Woo; X Yang; L Tin Lui; Q Li; K Fai Cheng; Y Fan; F Yau; A P W Lee; J S W Lee; E Fung
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Frailty Could Predict Death in Older Adults after Admissionat Emergency Department? A 6-month Prospective Study from a Middle-Income Country.

Authors:  I Aprahamian; G V Aricó de Almeida; C F de Vasconcellos Romanin; T Gomes Caldas; N T Antunes Yoshitake; L Bataglini; S Mori Lin; A Alves Pereira; L Nara Alegrini Longhi; R L Mamoni; J E Martinelli
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

3.  The role of CT for Covid-19 patient's management remains poorly defined.

Authors:  Yi Xiang J Wang; Wei-Hong Liu; Mo Yang; Wei Chen
Journal:  Ann Transl Med       Date:  2020-02

4.  Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; L Woodhouse; L Rodríguez-Mañas; L P Fried; J Woo; I Aprahamian; A Sanford; J Lundy; F Landi; J Beilby; F C Martin; J M Bauer; L Ferrucci; R A Merchant; B Dong; H Arai; E O Hoogendijk; C W Won; A Abbatecola; T Cederholm; T Strandberg; L M Gutiérrez Robledo; L Flicker; S Bhasin; M Aubertin-Leheudre; H A Bischoff-Ferrari; J M Guralnik; J Muscedere; M Pahor; J Ruiz; A M Negm; J Y Reginster; D L Waters; B Vellas
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

5.  Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.

Authors:  Philippe Colson; Jean-Marc Rolain; Jean-Christophe Lagier; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-04       Impact factor: 5.283

Review 6.  Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.

Authors:  Miguel Angel Martinez
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

7.  Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.

Authors:  Pengfei Sun; Shuyan Qie; Zongjian Liu; Jizhen Ren; Kun Li; Jianing Xi
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 20.693

8.  Remdesivir as a possible therapeutic option for the COVID-19.

Authors:  Jaffar A Al-Tawfiq; Ali H Al-Homoud; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-03-05       Impact factor: 6.211

9.  Editorial: Loneliness in Old Age: An unaddressed Health Problem.

Authors:  M Berg-Weger; J Morley
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

10.  Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.

Authors:  Yingxia Liu; Yang Yang; Cong Zhang; Fengming Huang; Fuxiang Wang; Jing Yuan; Zhaoqin Wang; Jinxiu Li; Jianming Li; Cheng Feng; Zheng Zhang; Lifei Wang; Ling Peng; Li Chen; Yuhao Qin; Dandan Zhao; Shuguang Tan; Lu Yin; Jun Xu; Congzhao Zhou; Chengyu Jiang; Lei Liu
Journal:  Sci China Life Sci       Date:  2020-02-09       Impact factor: 6.038

View more
  51 in total

1.  Loneliness in the time of COVID-19: Impact on older adults.

Authors:  Tamar Rodney; Nia Josiah; Diana-Lyn Baptiste
Journal:  J Adv Nurs       Date:  2021-04-14       Impact factor: 3.057

2.  The INSPIRE Bio-Resource Research Platform for Healthy Aging and Geroscience: Focus on the Human Translational Research Cohort (The INSPIRE-T Cohort).

Authors:  S Guyonnet; Y Rolland; C Takeda; P-J Ousset; I Ader; N Davezac; C Dray; N Fazilleau; P Gourdy; R Liblau; A Parini; P Payoux; L Pénicaud; C Rampon; P Valet; N Vergnolle; S Andrieu; P de Souto Barreto; L Casteilla; B Vellas
Journal:  J Frailty Aging       Date:  2021

3.  A spatio-temporal analysis for exploring the effect of temperature on COVID-19 early evolution in Spain.

Authors:  Álvaro Briz-Redón; Ángel Serrano-Aroca
Journal:  Sci Total Environ       Date:  2020-04-22       Impact factor: 7.963

4.  Sunlight exposure increased Covid-19 recovery rates: A study in the central pandemic area of Indonesia.

Authors:  Al Asyary; Meita Veruswati
Journal:  Sci Total Environ       Date:  2020-04-27       Impact factor: 7.963

5.  Changes in Daily Life during the COVID-19 Pandemic among South Korean Older Adults with Chronic Diseases: A Qualitative Study.

Authors:  Juah Kim; Yeonghun Kim; Jiyeon Ha
Journal:  Int J Environ Res Public Health       Date:  2021-06-24       Impact factor: 3.390

6.  COVID-19: a major cause of cachexia and sarcopenia?

Authors:  John E Morley; Kamyar Kalantar-Zadeh; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-06-09       Impact factor: 12.910

7.  Long-Term Care Facilities and the COVID-19 Pandemic: Lessons Learned in Madrid.

Authors:  Javier Martinez-Peromingo; Jose A Serra-Rexach
Journal:  J Am Geriatr Soc       Date:  2020-08-03       Impact factor: 7.538

8.  How a Barcelona Post-Acute Facility became a Referral Center for Comprehensive Management of Subacute Patients With COVID-19.

Authors:  Marco Inzitari; Cristina Udina; Oscar Len; Joan Ars; Cristina Arnal; Hugo Badani; Vanessa Davey; Ester Risco; Pere Ayats; Ana M de Andrés; Cristina Mayordomo; Francisco J Ros; Alessandro Morandi; Matteo Cesari
Journal:  J Am Med Dir Assoc       Date:  2020-06-11       Impact factor: 4.669

9.  Nutritional Considerations in Frail Older Patients with COVID-19.

Authors:  D Azzolino; E Saporiti; M Proietti; M Cesari
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 5.285

Review 10.  Immunosenescence is both functional/adaptive and dysfunctional/maladaptive.

Authors:  T Fulop; A Larbi; K Hirokawa; A A Cohen; J M Witkowski
Journal:  Semin Immunopathol       Date:  2020-09-15       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.